Company Performance Metrics
- John Pigott: Founder, Chief Science Officer, Director-VentureMed Group
- Dave Michaelson: Vice President of SalesPast Role: Urologix, Leadership Positions
Venture Med Group develops and markets a medical device system called the FLEX Vessel Prep™ System that aims to improve vessel preparation in procedures addressing arteriovenous access dysfunction and peripheral arterial disease. The system uses a mechanism of micro-incisions in the vessel wall to enhance vessel compliance, reduce trauma, and
facilitate subsequent therapies. It supports interventional physicians treating long or complex vascular lesions by offering an alternative to conventional balloon-only approaches. The company produces accompanying clinical data, reimbursement guidance, and device specifications to support use of the system.
